The extended human PTPome: a growing tyrosine phosphatase family

Tyr phosphatases are, by definition, enzymes that dephosphorylate phospho‐Tyr (pTyr) from proteins. This activity is found in several structurally diverse protein families, including the protein Tyr phosphatase (PTP), arsenate reductase, rhodanese, haloacid dehalogenase (HAD) and His phosphatase (HP) families. Most of these families include members with substrate specificity for non‐pTyr substrates, such as phospho‐Ser/phospho‐Thr, phosphoinositides, phosphorylated carbohydrates, mRNAs, or inorganic moieties. A Cys is essential for catalysis in PTPs, rhodanese and arsenate reductase enzymes, whereas this work is performed by an Asp in HAD phosphatases and by a His in HPs, via a catalytic mechanism shared by all of the different families. The category that contains most Tyr phosphatases is the PTP family, which, although it received its name from this activity, includes Ser, Thr, inositide, carbohydrate and RNA phosphatases, as well as some inactive pseudophosphatase proteins. Here, we propose an extended collection of human Tyr phosphatases, which we call the extended human PTPome. The addition of new members (SACs, paladin, INPP4s, TMEM55s, SSU72, and acid phosphatases) to the currently categorized PTP group of enzymes means that the extended human PTPome contains up to 125 proteins, of which ~ 40 are selective for pTyr. We set criteria to ascribe proteins to the extended PTPome, and summarize the more important features of the new PTPome members in the context of their phosphatase activity and their relationship with human disease.

[1]  Qiang Yu,et al.  Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis , 2013, Proceedings of the National Academy of Sciences.

[2]  S. Nagata,et al.  Characterization of the threonine–phosphatase of mouse eyes absent 3 , 2011, FEBS letters.

[3]  W. Frankel,et al.  A Null Mutation in Inositol Polyphosphate 4-Phosphatase Type I Causes Selective Neuronal Loss in Weeble Mutant Mice , 2001, Neuron.

[4]  L. Tabernero,et al.  Dual-specificity MAP kinase phosphatases as targets of cancer treatment. , 2011, Anti-cancer agents in medicinal chemistry.

[5]  E. Bottini,et al.  Cytosolic Low Molecular Weight Protein-Tyrosine Phosphatase Activity and Clinical Manifestations of Diabetes , 2014, The American journal of the medical sciences.

[6]  R. Hegde,et al.  The Eyes Absent proteins in development and disease , 2012, Cellular and Molecular Life Sciences.

[7]  S. Vincent,et al.  Regulation of ErbB4 phosphorylation and cleavage by a novel histidine acid phosphatase , 2004, Neuroscience.

[8]  N. Tonks,et al.  Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. , 1988, Biochemistry.

[9]  P. Nordlund,et al.  Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases. , 2014, Structure.

[10]  A. Orth,et al.  Negative Regulators of Insulin Signaling Revealed in a Genome-Wide Functional Screen , 2009, PloS one.

[11]  P. Doherty,et al.  Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. , 2004, Immunity.

[12]  M. Jadot,et al.  Acid phosphatase 5 is responsible for removing the mannose 6-phosphate recognition marker from lysosomal proteins , 2008, Proceedings of the National Academy of Sciences.

[13]  Diego Miranda-Saavedra,et al.  PTP-central: a comprehensive resource of protein tyrosine phosphatases in eukaryotic genomes. , 2014, Methods.

[14]  M. Bronner‐Fraser,et al.  Discovery of transcription factors and other candidate regulators of neural crest development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[15]  P. Parker,et al.  Sac phosphatase domain proteins. , 2000, The Biochemical journal.

[16]  Nicole Rusk,et al.  Role of Synaptojanin 2 in Glioma Cell Migration and Invasion , 2004, Cancer Research.

[17]  H. Macarthur,et al.  Covalent structure, disulfide bonding, and identification of reactive surface and active site residues of human prostatic acid phosphatase. , 1991, The Journal of biological chemistry.

[18]  J. Clohessy,et al.  In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes. , 2015, Cancer discovery.

[19]  Xun Li,et al.  The human DEPhOsphorylation database DEPOD: a 2015 update , 2014, Nucleic Acids Res..

[20]  E. Larsson,et al.  Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[21]  G. Ramponi,et al.  Low molecular weight protein tyrosine phosphatases: small, but smart , 2002, Cellular and Molecular Life Sciences CMLS.

[22]  C. Fedele,et al.  Phosphoinositide phosphatases: just as important as the kinases. , 2012, Sub-cellular biochemistry.

[23]  Sebastian A. Wagner,et al.  Regulation of ubiquitin-binding proteins by monoubiquitination , 2006, Nature Cell Biology.

[24]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[25]  J. R. Anderson,et al.  Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells. , 2001, The Journal of urology.

[26]  Karla J. Hutt,et al.  Paladin is an antiphosphatase that regulates neural crest cell formation and migration. , 2012, Developmental biology.

[27]  J. Dixon,et al.  Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome. , 2003, Molecular cell.

[28]  M. Ittmann,et al.  INPP4B: the New Kid on the PI3K Block , 2011, Oncotarget.

[29]  H. Augustin,et al.  Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets. , 2009, Chemistry & biology.

[30]  T. Meng,et al.  Tyrosine Phosphorylation of c-ErbB-2 Is Regulated by the Cellular Form of Prostatic Acid Phosphatase in Human Prostate Cancer Cells* , 1998, The Journal of Biological Chemistry.

[31]  David Kerk,et al.  Evolution of protein phosphatases in plants and animals. , 2009, The Biochemical journal.

[32]  G. Andersson,et al.  Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. , 2010, Experimental cell research.

[33]  D. McCormick,et al.  Essential Role of Phosphoinositide Metabolism in Synaptic Vesicle Recycling , 1999, Cell.

[34]  A. Jadhav,et al.  High-Throughput Screen Identifies Cyclic Nucleotide Analogs That Inhibit Prostatic Acid Phosphatase , 2013, Journal of biomolecular screening.

[35]  A. Pause,et al.  Pseudophosphatases: methods of analysis and physiological functions. , 2014, Methods.

[36]  K D Watenpaugh,et al.  Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. , 1999, Journal of molecular biology.

[37]  J. Batra,et al.  A genetic variation in inositol polyphosphate 4 phosphatase a enhances susceptibility to asthma. , 2008, American journal of respiratory and critical care medicine.

[38]  R. Pulido,et al.  Protein tyrosine phosphatases in health and disease , 2013, The FEBS journal.

[39]  T. Cox,et al.  Tartrate‐Resistant Acid Phosphatase Knockout Mice , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Liang Tong,et al.  Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex , 2010, Nature.

[41]  M. Klein,et al.  Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder , 2001, Molecular Psychiatry.

[42]  C. Mitchell,et al.  Inositol polyphosphate phosphatases in human disease. , 2012, Current topics in microbiology and immunology.

[43]  J. den Hertog,et al.  Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha. , 1999, Biochemistry.

[44]  Ming-Shyue Lee,et al.  Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases. , 2009, Trends in biochemical sciences.

[45]  Kamraan Z. Gill,et al.  A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms. , 2014, The Journal of investigative dermatology.

[46]  M. Kontturi Is acid phosphatase (PAP) still justified in the management of prostatic cancer? , 1991, Acta oncologica.

[47]  D. Hochhauser,et al.  Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment , 2015, Oncotarget.

[48]  Su-Jae Lee,et al.  Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells , 2012, Cancer biology & therapy.

[49]  Juan Zhang,et al.  Once Phosphorylated, Tyrosines in Carboxyl Terminus of Protein-tyrosine Kinase Syk Interact with Signaling Proteins, Including TULA-2, a Negative Regulator of Mast Cell Degranulation* , 2012, The Journal of Biological Chemistry.

[50]  H. Väänänen,et al.  Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. , 2006, Clinical laboratory.

[51]  J. Lupski,et al.  Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J , 2007, Nature.

[52]  D. Hume,et al.  Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatases. , 2004, Archives of biochemistry and biophysics.

[53]  P. De Camilli,et al.  Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome , 2008, Proceedings of the National Academy of Sciences.

[54]  G. Andersson,et al.  The tartrate-resistant purple acid phosphatase of bone osteoclasts--a protein phosphatase with multivalent substrate specificity and regulation. , 1995, Acta orthopaedica Scandinavica. Supplementum.

[55]  P G Drake,et al.  Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.

[56]  M. Barbe,et al.  TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function , 2012, Cellular and Molecular Life Sciences.

[57]  S. Nagata,et al.  Regulation of the innate immune response by threonine-phosphatase of Eyes absent , 2009, Nature.

[58]  Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins , 1989 .

[59]  H. Nakanishi,et al.  INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor. , 2015, Cancer discovery.

[60]  P. Comba,et al.  Purple acid phosphatase: a journey into the function and mechanism of a colorful enzyme , 2013 .

[61]  P. De Camilli,et al.  Functional Characterization of a Mammalian Sac1 and Mutants Exhibiting Substrate-specific Defects in Phosphoinositide Phosphatase Activity* , 2000, The Journal of Biological Chemistry.

[62]  C. Eng,et al.  Protean PTEN: form and function. , 2002, American journal of human genetics.

[63]  Michel G. Arsenault,et al.  Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans. , 2011, Cell metabolism.

[64]  J. Bear,et al.  The Sac1 phosphoinositide phosphatase regulates Golgi membrane morphology and mitotic spindle organization in mammals. , 2008, Molecular biology of the cell.

[65]  J. Thornton,et al.  Elucidating Human Phosphatase-Substrate Networks , 2013, Science Signaling.

[66]  M. Hampsey,et al.  The Essential N Terminus of the Pta1 Scaffold Protein Is Required for snoRNA Transcription Termination and Ssu72 Function but Is Dispensable for Pre-mRNA 3′-End Processing , 2009, Molecular and Cellular Biology.

[67]  T. Takenawa,et al.  Sac3 Is an Insulin-regulated Phosphatidylinositol 3,5-Bisphosphate Phosphatase , 2009, The Journal of Biological Chemistry.

[68]  G. Schneider,et al.  Three‐dimensional structure of rat acid phosphatase. , 1993, The EMBO journal.

[69]  N. Tonks Protein Tyrosine Phosphatases: From Housekeeping Enzymes to Master-Regulators of Signal Transduction , 2013 .

[70]  C. Heldin,et al.  Suppressors of T-cell Receptor Signaling Sts-1 and Sts-2 Bind to Cbl and Inhibit Endocytosis of Receptor Tyrosine Kinases* , 2004, Journal of Biological Chemistry.

[71]  C. Chou,et al.  Structures of Selenomonas ruminantium phytase in complex with persulfated phytate: DSP phytase fold and mechanism for sequential substrate hydrolysis. , 2004, Structure.

[72]  Y. Mao,et al.  The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis. , 2015, Biochimica et biophysica acta.

[73]  N. Tonks,et al.  Characterization of the major protein-tyrosine-phosphatases of human placenta. , 1988, The Journal of biological chemistry.

[74]  E. Fauman,et al.  Crystal Structure of the Catalytic Domain of the Human Cell Cycle Control Phosphatase, Cdc25A , 1998, Cell.

[75]  P. Cramer,et al.  The mRNA Transcription/Processing Factor Ssu72 Is a Potential Tyrosine Phosphatase* , 2003, The Journal of Biological Chemistry.

[76]  L. Lebioda,et al.  Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha-benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insights into inhibitor design. , 2002, Biochemistry.

[77]  T. Ahmad,et al.  Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase (INPP4A). , 2012, International immunopharmacology.

[78]  A. Suzuki,et al.  Mammalian phosphoinositide kinases and phosphatases. , 2009, Progress in lipid research.

[79]  T. Chao,et al.  Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[80]  T. Takenawa,et al.  Core Protein Machinery for Mammalian Phosphatidylinositol 3,5-Bisphosphate Synthesis and Turnover That Regulates the Progression of Endosomal Transport , 2007, Journal of Biological Chemistry.

[81]  L. Tong,et al.  An unexpected binding mode for a Pol II CTD peptide phosphorylated at Ser7 in the active site of the CTD phosphatase Ssu72. , 2012, Genes & development.

[82]  M. Myers,et al.  The pseudophosphatase MK-STYX interacts with G3BP and decreases stress granule formation , 2010, The Biochemical journal.

[83]  佐野 晃之 Regulation of the innate immune response by threonine-phosphatase of eyes absent and the characterization of their phosphatase activity , 2012 .

[84]  M. Ferrer,et al.  Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell Migration* , 2014, The Journal of Biological Chemistry.

[85]  James H. Hurley,et al.  Specificity Determinants in Phosphoinositide Dephosphorylation Crystal Structure of an Archetypal Inositol Polyphosphate 5-Phosphatase , 2001, Cell.

[86]  S. Koo,et al.  C1-Ten Is a Protein Tyrosine Phosphatase of Insulin Receptor Substrate 1 (IRS-1), Regulating IRS-1 Stability and Muscle Atrophy , 2013, Molecular and Cellular Biology.

[87]  T. Takenawa,et al.  Identification and Characterization of a Sac Domain-containing Phosphoinositide 5-Phosphatase* , 2001, The Journal of Biological Chemistry.

[88]  Yuzhuo Wang,et al.  INPP4B suppresses prostate cancer cell invasion , 2014, Cell Communication and Signaling.

[89]  K. Lau,et al.  Purification and characterization of an acid phosphatase that displays phosphotyrosyl-protein phosphatase activity from bovine cortical bone matrix. , 1987, The Journal of biological chemistry.

[90]  W. Hol,et al.  The covalent and tertiary structure of bovine liver rhodanese , 1978, Nature.

[91]  G. Giles,et al.  Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers , 2010, Proceedings of the National Academy of Sciences.

[92]  E. L. Scolan,et al.  Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene , 2006, Oncogene.

[93]  A. Janecke,et al.  Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity , 2011, Nature Genetics.

[94]  J. Dixon,et al.  Gathering STYX: phosphatase-like form predicts functions for unique protein-interaction domains. , 1998, Trends in biochemical sciences.

[95]  I. Madshus,et al.  The Cbl-interacting protein TULA inhibits dynamin-dependent endocytosis. , 2007, Experimental cell research.

[96]  M. Bhasin,et al.  Bioinformatic identification and characterization of human endothelial cell-restricted genes , 2010, BMC Genomics.

[97]  Samuel Bouyain,et al.  Protein tyrosine phosphatases. , 2015, Seminars in cell & developmental biology.

[98]  M. Meisler,et al.  Congenital CNS Hypomyelination in the Fig4 Null Mouse Is Rescued by Neuronal Expression of the PI(3,5)P2 Phosphatase Fig4 , 2011, The Journal of Neuroscience.

[99]  A. Hayman Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy , 2008, Autoimmunity.

[100]  Wen Hwa Lee,et al.  Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome , 2009, Cell.

[101]  E. Messing,et al.  Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. , 2014 .

[102]  Robert H. Brown,et al.  Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. , 2009, American journal of human genetics.

[103]  Leif E. Peterson,et al.  Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. , 2011, Cancer research.

[104]  H. Schlüter,et al.  Mannose 6 Dephosphorylation of Lysosomal Proteins Mediated by Acid Phosphatases Acp2 and Acp5 , 2011, Molecular and Cellular Biology.

[105]  R. Kobayashi,et al.  Identification, cDNA Cloning, and Targeted Deletion of p70, a Novel, Ubiquitously Expressed SH3 Domain-Containing Protein , 2002, Molecular and Cellular Biology.

[106]  S. Batra,et al.  Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. , 2014, Biochimica et biophysica acta.

[107]  N. Nassar,et al.  A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling. , 2007, Molecular cell.

[108]  C. Glass,et al.  Eya protein phosphatase activity regulates Six1–Dach–Eya transcriptional effects in mammalian organogenesis , 2003, Nature.

[109]  S. Carr,et al.  TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin , 2004, Oncogene.

[110]  J. MacKeigan,et al.  The Pseudophosphatase MK-STYX Physically and Genetically Interacts with the Mitochondrial Phosphatase PTPMT1 , 2014, PloS one.

[111]  L. Lebioda,et al.  Crystal structure of human prostatic acid phosphatase , 2000, The Prostate.

[112]  S. Hardy,et al.  Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.

[113]  L. Tautz,et al.  Protein tyrosine phosphatases: structure, function, and implication in human disease. , 2013, Methods in molecular biology.

[114]  R. Maas,et al.  Mouse Eya homologues of the Drosophila eyes absent gene require Pax6 for expression in lens and nasal placode. , 1997, Development.

[115]  K. To,et al.  Epigenetic Inactivation of Inositol polyphosphate 4-phosphatase B (INPP4B), a Regulator of PI3K/AKT Signaling Pathway in EBV-Associated Nasopharyngeal Carcinoma , 2014, PloS one.

[116]  C. Lee,et al.  Homodimer and heterodimer subunits of human prostate acid phosphatase. , 1991, The Biochemical journal.

[117]  Eeva-Liisa Eskelinen,et al.  Prostatic acid phosphatase is not a prostate specific target. , 2007, Cancer research.

[118]  F. Ahmad,et al.  Structural and functional analysis of human prostatic acid phosphatase , 2010, Expert review of anticancer therapy.

[119]  L. Costa,et al.  The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis , 2013, Tumor Biology.

[120]  J. Whisstock,et al.  The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane. , 2005, Molecular biology of the cell.

[121]  J. Tanner,et al.  Redox regulation of protein tyrosine phosphatases: structural and chemical aspects. , 2011, Antioxidants & redox signaling.

[122]  A. Ostman,et al.  Regulation of protein tyrosine phosphatases by reversible oxidation. , 2011, Journal of biochemistry.

[123]  T. Ahmad,et al.  Loss-of-function of inositol polyphosphate-4-phosphatase reversibly increases the severity of allergic airway inflammation , 2012, Nature Communications.

[124]  M. Minden,et al.  INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia , 2015, Leukemia.

[125]  P. Heneberg Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. , 2009, Current medicinal chemistry.

[126]  S. Kunapuli,et al.  A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets. , 2008, Blood.

[127]  L. Salmena,et al.  Phosphoinositide signaling in cancer: INPP4B Akt(s) out. , 2015, Trends in molecular medicine.

[128]  Rameen Beroukhim,et al.  SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. , 2014, Molecular cell.

[129]  M. Bronner‐Fraser,et al.  Genomic analysis of neural crest induction , 2002, Development.

[130]  M. Peppelenbosch,et al.  From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase , 2009, Cellular and Molecular Life Sciences.

[131]  G. Clinton,et al.  The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase. , 1988, Molecular and cellular biology.

[132]  N. Carpino,et al.  Insights into the suppressor of T‐cell receptor (TCR) signaling‐1 (Sts‐1)‐mediated regulation of TCR signaling through the use of novel substrate‐trapping Sts‐1 phosphatase variants , 2014, The FEBS journal.

[133]  A. Bennett,et al.  Mining the function of protein tyrosine phosphatases in health and disease. , 2015, Seminars in cell & developmental biology.

[134]  Y. Mao,et al.  Identification and Structural Characterization of a Legionella Phosphoinositide Phosphatase* , 2013, The Journal of Biological Chemistry.

[135]  A. Elson,et al.  Protein tyrosine phosphatases: functional inferences from mouse models and human diseases , 2008, The FEBS journal.

[136]  S. Mosimann,et al.  Kinetic and structural analysis of a bacterial protein tyrosine phosphatase‐like myo‐inositol polyphosphatase , 2007, Protein science : a publication of the Protein Society.

[137]  F. Pontén,et al.  Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development , 2012, Developmental Dynamics.

[138]  R. Pulido PTEN: a yin-yang master regulator protein in health and disease. , 2015, Methods.

[139]  R. Shinde,et al.  Protein tyrosine phosphatase inhibitors: a patent review (2002 – 2011) , 2012, Expert opinion on therapeutic patents.

[140]  Zhon-Yin Zhang,et al.  Small molecule tools for functional interrogation of protein tyrosine phosphatases , 2013, The FEBS journal.

[141]  A. Tsygankov,et al.  TULA proteins regulate activity of the protein tyrosine kinase Syk , 2008, Journal of cellular biochemistry.

[142]  R. Annan,et al.  T-cell Ubiquitin Ligand Affects Cell Death through a Functional Interaction with Apoptosis-inducing Factor, a Key Factor of Caspase-independent Apoptosis* , 2007, Journal of Biological Chemistry.

[143]  H. Ding,et al.  Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3. , 2014, Urologic oncology.

[144]  J. Manley,et al.  The RNA polymerase II CTD coordinates transcription and RNA processing. , 2012, Genes & development.

[145]  R. Pulido,et al.  PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease. , 2013, Human molecular genetics.

[146]  G. Clinton,et al.  Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity. , 1986, The Biochemical journal.

[147]  K. Patterson,et al.  Dual-specificity phosphatases: critical regulators with diverse cellular targets. , 2009, The Biochemical journal.

[148]  Owen W. Ryan,et al.  Conserved and specific functions of mammalian ssu72 , 2005, Nucleic acids research.

[149]  P. Vihko,et al.  Studies on the protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase. , 1998, Archives of biochemistry and biophysics.

[150]  Lalima G. Ahuja,et al.  Bi-domain protein tyrosine phosphatases reveal an evolutionary adaptation to optimize signal transduction. , 2014, Antioxidants & redox signaling.

[151]  J. Dixon,et al.  The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease* , 2005, Journal of Biological Chemistry.

[152]  P. Murray,et al.  Acid phosphatases , 2002, Molecular pathology : MP.

[153]  S. Chevalier,et al.  Phosphotyrosine phosphatase activity of human and canine acid phosphatases of prostatic origin , 1988, The Prostate.

[154]  N. Tonks,et al.  Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. , 1991, Science.

[155]  T. Takenawa,et al.  The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death , 2010, Nature.

[156]  S. Emr,et al.  Crystal structure of the yeast Sac1: implications for its phosphoinositide phosphatase function , 2010, The EMBO journal.

[157]  Hansoo Lee,et al.  Endogenous protein substrates for prostatic acid phosphatase in human prostate , 1991, The Prostate.

[158]  S. Srivastava,et al.  Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. , 2005, Endocrine-related cancer.

[159]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[160]  S. Hanks,et al.  Genomic analysis of the eukaryotic protein kinase superfamily: a perspective , 2003, Genome Biology.

[161]  Ying Sun,et al.  INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells , 2014, Tumor Biology.

[162]  S. Carr,et al.  TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin , 2004, Oncogene.

[163]  Jung-Sik Kim,et al.  Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors , 2009, EMBO molecular medicine.

[164]  Toshiyuki Fukada,et al.  A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[165]  A. H. Ullah,et al.  The term phytase comprises several different classes of enzymes. , 2003, Biochemical and biophysical research communications.

[166]  A. Bolino,et al.  Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. , 2012, Trends in molecular medicine.

[167]  J. Epstein,et al.  Inpp5f Is a Polyphosphoinositide Phosphatase That Regulates Cardiac Hypertrophic Responsiveness , 2009, Circulation research.

[168]  S. Harrison,et al.  Structure of the PTEN-like region of auxilin, a detector of clathrin-coated vesicle budding. , 2010, Structure.

[169]  T. Tan,et al.  DUSPs, to MAP kinases and beyond , 2012, Cell & Bioscience.

[170]  R. Hegde,et al.  Structure-Activity Relationships of Benzbromarone Metabolites and Derivatives as EYA Inhibitory Anti-Angiogenic Agents , 2013, PloS one.

[171]  B. Kholodenko,et al.  Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2 , 2013, Proceedings of the National Academy of Sciences.

[172]  N. Tonks,et al.  Protein tyrosine phosphatases: from genes, to function, to disease , 2006, Nature Reviews Molecular Cell Biology.

[173]  N. Tonks Redox Redux: Revisiting PTPs and the Control of Cell Signaling , 2005, Cell.

[174]  Hyun-Soo Kim,et al.  The hsSsu72 phosphatase is a cohesin‐binding protein that regulates the resolution of sister chromatid arm cohesion , 2010, The EMBO journal.

[175]  S. Antonarakis,et al.  Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains , 2001, Human Genetics.

[176]  K. Hollberg,et al.  TRACP as an Osteopontin Phosphatase , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[177]  D. Heinegård,et al.  Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. , 1994, The Journal of biological chemistry.

[178]  P. Pandolfi,et al.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. , 2009, Cancer cell.

[179]  P. Majerus,et al.  The role of inositol polyphosphate 4-phosphatase 1 in platelet function using a weeble mouse model. , 2011, Advances in enzyme regulation.

[180]  Gerald C. Chu,et al.  Proinvasion metastasis drivers in early-stage melanoma are oncogenes. , 2011, Cancer cell.

[181]  G. Mardon,et al.  Eyes absent represents a class of protein tyrosine phosphatases , 2003, Nature.

[182]  Frédéric Devaux,et al.  Ssu72 is a phosphatase essential for transcription termination of snoRNAs and specific mRNAs in yeast , 2003, The EMBO journal.

[183]  Bernard Ducommun,et al.  The when and wheres of CDC25 phosphatases. , 2006, Current opinion in cell biology.

[184]  Lydia Tabernero,et al.  Protein tyrosine phosphatase structure–function relationships in regulation and pathogenesis , 2013, The FEBS journal.

[185]  C. Allis,et al.  Dephosphorylation of the C-terminal Tyrosyl Residue of the DNA Damage-related Histone H2A.X Is Mediated by the Protein Phosphatase Eyes Absent* , 2009, The Journal of Biological Chemistry.

[186]  C. Li,et al.  Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase. , 1992, Leukemia.

[187]  N. Nassar,et al.  Structural and functional characterization of the 2H-phosphatase domain of Sts-2 reveals an acid-dependent phosphatase activity. , 2009, Biochemistry.

[188]  Yan Zhang,et al.  Crystal structure of Ssu72, an essential eukaryotic phosphatase specific for the C-terminal domain of RNA polymerase II, in complex with a transition state analogue. , 2011, The Biochemical journal.

[189]  N. Nicely,et al.  cis-Proline-mediated Ser(P)5 Dephosphorylation by the RNA Polymerase II C-terminal Domain Phosphatase Ssu72* , 2010, The Journal of Biological Chemistry.

[190]  N. Nassar,et al.  Structural and functional characterization of the c-terminal domain of the ecdysteroid phosphate phosphatase from bombyx mori reveals a new enzymatic activity. , 2008, Biochemistry.

[191]  M. Zylka,et al.  Prostatic Acid Phosphatase Is an Ectonucleotidase and Suppresses Pain by Generating Adenosine , 2008, Neuron.

[192]  A. Papenfuss,et al.  Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML. , 2015, Blood.

[193]  J. Rudolph,et al.  Catalytic mechanism of Cdc25. , 2002, Biochemistry.

[194]  I. Agoulnik,et al.  Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities. , 2013, Biochemical and biophysical research communications.

[195]  Sheila J. Jones,et al.  Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice. , 2001, Development.

[196]  M. Meisler,et al.  Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2 , 2009, Human molecular genetics.

[197]  A. Tsygankov TULA‐family proteins: A new class of cellular regulators , 2013, Journal of cellular physiology.

[198]  P. Shi,et al.  Diversity, abundance and characterization of ruminal cysteine phytases suggest their important role in phytate degradation. , 2011, Environmental microbiology.

[199]  M. Washburn,et al.  Ssu72 Phosphatase-dependent Erasure of Phospho-Ser7 Marks on the RNA Polymerase II C-terminal Domain Is Essential for Viability and Transcription Termination* , 2012, The Journal of Biological Chemistry.

[200]  M. Zylka,et al.  Prostatic Acid Phosphatase Is Required for the Antinociceptive Effects of Thiamine and Benfotiamine , 2012, PloS one.

[201]  M. Hampsey,et al.  Synthetic enhancement of a TFIIB defect by a mutation in SSU72, an essential yeast gene encoding a novel protein that affects transcription start site selection in vivo , 1996, Molecular and cellular biology.

[202]  César L. Araujo,et al.  Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma , 2013, PloS one.

[203]  Suk-Kyeong Jung,et al.  Crystal structure of ED‐Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[204]  P. Majerus,et al.  The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[205]  G. Yousef,et al.  Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis. , 2001, Genomics.

[206]  S. Tominaga,et al.  Cooperation of Six and Eya in Activation of Their Target Genes through Nuclear Translocation of Eya , 1999, Molecular and Cellular Biology.

[207]  G. M. Arantes The catalytic acid in the dephosphorylation of the Cdk2-pTpY/CycA protein complex by Cdc25B phosphatase. , 2008, The journal of physical chemistry. B.

[208]  R. Pulido,et al.  Protein tyrosine phosphatases: dual‐specificity phosphatases in health and disease , 2008, The FEBS journal.

[209]  P. Majerus,et al.  Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis , 2007, Proceedings of the National Academy of Sciences.

[210]  Michael Hampsey,et al.  Ssu72 Is an RNA polymerase II CTD phosphatase. , 2004, Molecular cell.

[211]  J. Selengut,et al.  The transcription factor Eyes absent is a protein tyrosine phosphatase , 2003, Nature.

[212]  Hyun-soo Cho,et al.  Functional interplay between Aurora B kinase and Ssu72 phosphatase regulates sister chromatid cohesion , 2013, Nature Communications.

[213]  Christopher K. Glass,et al.  Tyrosine Dephosphorylation of H2AX Modulates Apoptosis and Survival Decisions , 2009, Nature.

[214]  G. Ramponi,et al.  Structure and function of the low Mr phosphotyrosine protein phosphatases. , 1997, Biochimica et biophysica acta.

[215]  Yaping Tu,et al.  Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth* , 2010, The Journal of Biological Chemistry.

[216]  M. Bahlo,et al.  A Mutation in Synaptojanin 2 Causes Progressive Hearing Loss in the ENU-Mutagenised Mouse Strain Mozart , 2011, PloS one.

[217]  Jack E. Dixon,et al.  Crystal Structure of the Dual Specificity Protein Phosphatase VHR , 1996, Science.

[218]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases (MKPs) , 2013, The FEBS journal.

[219]  P. Söderkvist,et al.  Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung , 2014, Cancer medicine.

[220]  Daniel J Rigden,et al.  The histidine phosphatase superfamily: structure and function. , 2008, Biochemical Journal.